FOURTH AMENDING LEASE AGREEMENTFourth Amending Lease Agreement • May 14th, 2007 • NUCRYST Pharmaceuticals Corp. • Surgical & medical instruments & apparatus
WHEREAS THE WESTAIM CORPORATION (“Lessor”) and NUCRYST PHARMACEUTICALS CORP. (“Lessee”) entered into a Memorandum of Lease Agreement dated July 1, 2005 (the“ Original Lease Agreement”) which was amended by Letter Agreement dated November 14, 2005 (the “First Amending Lease Agreement”), by a second amending lease agreement dated April 27, 2006 (the “Second Amending Lease Agreement”) and by a third amending lease agreement dated August 8, 2006 (the “Third Amending Lease Agreement”) collectively the “Lease Agreement”;
AIMS I SECOND AMENDING LEASE AGREEMENTAims I Second Amending Lease Agreement • May 14th, 2007 • NUCRYST Pharmaceuticals Corp. • Surgical & medical instruments & apparatus
WHEREAS THE WESTAIM CORPORATION (“Lessor”) and NUCRYST PHARMACEUTICALS CORP. (“Lessee”) entered into a Memorandum of Lease Agreement dated effective December 1st, 2005 (the “Aims I Lease Agreement”) which was amended by that Aims I Amending Lease Agreement dated December 22, 2006 (collectively the “Lease Agreement”);
Re: Sale by The Westaim Corporation to Sherritt International Inc. (the “Sale”) of the lands legally described as Lot 49 Block 1 Plan 042 4648; Lot 3 Plan 912 0267; Lot 27 Plan 962 3802; and, Lot 46, Block 1, Plan 032 6168; (the “Lands”) to close on...NUCRYST Pharmaceuticals Corp. • May 14th, 2007 • Surgical & medical instruments & apparatus
It is hereby mutually agreed between Westaim and Nucryst that, in order to facilitate the Sale, and subject to the closing thereof:
